See more : L E Lundbergföretagen AB (publ) (0GWB.IL) Income Statement Analysis – Financial Results
Complete financial analysis of OneMedNet Corporation (ONMD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of OneMedNet Corporation, a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
You may be interested
- Power Metals Corp. (PWM.V) Income Statement Analysis – Financial Results
- Interlink Communication Public Company Limited (ILINK.BK) Income Statement Analysis – Financial Results
- D&G Technology Holding Company Limited (1301.HK) Income Statement Analysis – Financial Results
- Butler National Corporation (BUKS) Income Statement Analysis – Financial Results
- Intellipharmaceutics International Inc. (IPCI.TO) Income Statement Analysis – Financial Results
OneMedNet Corporation (ONMD)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.onemednet.com
About OneMedNet Corporation
OneMedNet Corporation develops technology that focuses on accessing and sharing health data. It offers BEAM Medical Image Exchange & Management Suite, a solution that manages, exchanges, and shares medical images with patients, care providers, and hospitals. The company was founded in 2009 and is based in Eden Prairie, Minnesota with a development office in Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 1.02M | 1.15M | 1.09M | 824.03K |
| Cost of Revenue | 1.15M | 1.51M | 1.21M | 611.66K |
| Gross Profit | -127.90K | -360.69K | -113.41K | 212.37K |
| Gross Profit Ratio | -12.52% | -31.29% | -10.39% | 25.77% |
| Research & Development | 1.63M | 952.70K | 642.77K | 307.27K |
| General & Administrative | 5.27M | 3.45M | 1.20M | 2.06M |
| Selling & Marketing | 1.11M | 957.69K | 605.24K | 318.41K |
| SG&A | 6.61M | 4.40M | 1.80M | 2.38M |
| Other Expenses | 0.00 | -46.82K | -34.91K | -83.00K |
| Operating Expenses | 6.72M | 5.76M | 2.60M | 3.14M |
| Cost & Expenses | 7.87M | 7.27M | 3.80M | 3.76M |
| Interest Income | 0.00 | 0.00 | 0.00 | 193.55K |
| Interest Expense | 749.21K | 403.31K | 195.38K | 0.00 |
| Depreciation & Amortization | 28.00K | 24.81K | 14.47K | 13.92K |
| EBITDA | -22.43M | -5.59M | -2.70M | -2.92M |
| EBITDA Ratio | -2,195.30% | -532.49% | -250.14% | -354.14% |
| Operating Income | -8.37M | -6.16M | -2.71M | -2.93M |
| Operating Income Ratio | -819.68% | -534.48% | -248.27% | -355.83% |
| Total Other Income/Expenses | -14.83M | 146.38K | -230.29K | 110.55K |
| Income Before Tax | -23.21M | -6.57M | -2.94M | -2.82M |
| Income Before Tax Ratio | -2,271.37% | -569.63% | -269.37% | -342.41% |
| Income Tax Expense | 0.00 | 356.49K | 160.47K | -193.55K |
| Net Income | -23.21M | -6.57M | -2.94M | -2.82M |
| Net Income Ratio | -2,271.37% | -569.63% | -269.37% | -342.41% |
| EPS | -4.77 | -1.36 | -0.61 | -0.58 |
| EPS Diluted | -4.77 | -0.20 | -0.09 | -0.09 |
| Weighted Avg Shares Out | 7.08M | 4.84M | 4.84M | 4.84M |
| Weighted Avg Shares Out (Dil) | 7.08M | 32.26M | 32.26M | 32.26M |
OneMedNet Announces Exciting New Collaboration with Bayer's AI Innovation Platform to Help Accelerate Healthcare AI Development
MINNEAPOLIS, Dec. 02, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), a Real-World Data (RWD) platform — has announced its collaboration with Bayer's AI Innovation Platform (AIIP). By joining AIIP, the partnership aims to empower the...
OneMedNet Announces Receipt of Nasdaq Notice Regarding Delayed Form 10-Q
MINNEAPOLIS, Nov. 27, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data (“iRWD™”), inclusive of electronic health records, laboratory results and, uniquely,...
OneMedNet Announces Continued Investment into Bitcoin
MINNEAPOLIS, Nov. 12, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), a pioneer in curating regulatory-grade Real World Data (RWD) including electronic health records, laboratory results, and medical imaging, has announced an additional strategic investment in...
OneMedNet Announces Board Member Transition to Drive Growth Post-IPO
MINNEAPOLIS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (RWD), is pleased to announce a strategic refresh of its Board of Directors following the successful transition...
OneMedNet Announces Additional $1.7 Million Private Placement
MINNEAPOLIS, Sept. 26, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data ("RWD"), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, today announced that it has...
OneMedNet Announces Receipt of Nasdaq Notices Regarding Delayed Forms 10-Q
MINNEAPOLIS, Sept. 12, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data ("RWD"), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, today announced the Company received...
OneMedNet appoints new CFO
MINNEAPOLIS, Sept. 10, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (RWD), has announced that Bob Golden has joined the OneMedNet Executive Team as Chief Financial Officer spearheading...
OneMedNet Revolutionizes Data Curation with AI, Boosting Efficiency up to 5X
MINNEAPOLIS, Aug. 09, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (RWD), has successfully integrated its proprietary AI technology into its data curation process, ensuring rapid and precise...
OneMedNet Announces $4.6 Million Private Placement
Institutional investors include affiliates of Off the Chain Capital and Discovery Capital Management Institutional investors include affiliates of Off the Chain Capital and Discovery Capital Management
Cytel Unveiled as OneMedNet's Newest Alliance Partner
Cytel's software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companies Cytel's software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companies
Source: https://incomestatements.info
Category: Stock Reports